keyword
https://read.qxmd.com/read/38672442/utilization-of-diverse-molecules-as-receptors-by-cry-toxin-and-the-promiscuous-nature-of-receptor-binding-sites-which-accounts-for-the-diversity
#1
REVIEW
Ryoichi Sato
By 2013, it had been shown that the genes cadherin-like receptor (Cad) and ATP-binding cassette transporter subfamily C2 (ABCC2) were responsible for insect resistance to several Cry1A toxins, acting as susceptibility-determining receptors, and many review articles have been published. Therefore, this review focuses on information about receptors and receptor-binding sites that have been revealed since 2014. Since 2014, studies have revealed that the receptors involved in determining susceptibility vary depending on the Cry toxin subfamily, and that binding affinity between Cry toxins and receptors plays a crucial role...
April 1, 2024: Biomolecules
https://read.qxmd.com/read/38665153/genes-involved-in-metastasis-in-oral-squamous-cell-carcinoma-a-systematic-review
#2
JOURNAL ARTICLE
Nooshin Mohtasham, Marzieh Zarepoor, Zahra Shooshtari, Kiana Kamyab Hesari, Farnaz Mohajertehran
BACKGROUND AND AIMS: Oral squamous cell carcinoma is the most prevalent malignancy in the oral cavity, with a significant mortality rate. In oral squamous cell carcinoma patients, the survival rate could decrease because of delayed diagnosis. Thus, prevention, early diagnosis, and appropriate treatment can effectively increase the survival rate in patients. In this systematic review, we discussed the role of different genes in oral squamous cell carcinoma metastasis. Herein, we aimed to summarize clinical results, regarding the potential genes that promote oral squamous cell carcinoma metastasis...
April 2024: Health Science Reports
https://read.qxmd.com/read/38645422/navigating-uncharted-territory-a-case-report-and-literature-review-on-the-remarkable-response-to-personalized-crizotinib-containing-combinational-therapy-in-a-pazopanib-refractory-patient-with-novel-alterations
#3
Esranur Aydın, Ünal Metin Tokat, Eylül Özgü, Ashkan Adibi, Onur Tutar, Razelle Kurzrock, Mutlu Demiray
This paper presents a patient with a novel Ig-like-III domain fibroblast growth factor receptor (FGFR2) alteration (W290_P307>C) along with CDKN2A/B alterations and a cadherin 1 (CDH1) alteration. Initial responsiveness to pazopanib monotherapy was encouraging, yet progression occurred after 7.5 months. Following progression, the molecular tumor board recommended a combination therapy approach comprising pazopanib, crizotinib, and palbociclib to target all of the changed pathways at the same time...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38628658/selected-markers-of-ovarian-cancer-and-their-relation-to-targeted-therapy-review
#4
REVIEW
Anna Markowska, Zbigniew Kojs, Damian Twardawa, Joanna Pietras, Janina Markowska
Despite advances in surgical treatment techniques and chemotherapy-including anti-angiogenic and immune poly (ADP-ribose) polymerase inhibitors, the 5-year survival rate in ovarian cancer (OC) remains low. The reasons for this are the diagnosis of cancer in advanced clinical stages, chemoresistance and cancer recurrence. New therapeutic approaches are being developed, including the search for new biomarkers that are also targets for targeted therapy. The present review describes new molecular markers with relevance to targeted therapy, which to date have been studied only in experimental research...
May 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38618992/microenvironment-induced-restoration-of-cohesive-growth-associated-with-focal-activation-of-p-cadherin-expression-in-lobular-breast-carcinoma-metastatic-to-the-colon
#5
JOURNAL ARTICLE
Malte Gronewold, Isabel Grote, Stephan Bartels, Henriette Christgen, Leonie D Kandt, Maria Jose Brito, Gàbor Cserni, Maximilian E Daemmrich, Franz Fogt, Burkhard M Helmke, Natalie Ter Hoeve, Corinna Lang-Schwarz, Michael Vieth, Axel Wellmann, Elna Kuehnle, Ulf Kulik, Gesa Riedel, Tanja Reineke-Plaass, Ulrich Lehmann, Thijs Koorman, Patrick Wb Derksen, Hans Kreipe, Matthias Christgen
Invasive lobular carcinoma (ILC) is a special breast cancer type characterized by noncohesive growth and E-cadherin loss. Focal activation of P-cadherin expression in tumor cells that are deficient for E-cadherin occurs in a subset of ILCs. Switching from an E-cadherin deficient to P-cadherin proficient status (EPS) partially restores cell-cell adhesion leading to the formation of cohesive tubular elements. It is unknown what conditions control EPS. Here, we report on EPS in ILC metastases in the large bowel...
March 2024: Journal of Pathology. Clinical Research
https://read.qxmd.com/read/38613589/subcellular-expression-of-mta1-hif1a-and-p53-in-primary-tumor-predicts-aggressive-triple-negative-breast-cancers-a-meta-analysis-based-study
#6
JOURNAL ARTICLE
Shanaz S Sharaf, K M Jaganath Krishna, Asha Lekshmi, Sujathan
BACKGROUND: The prevalence of TNBC in India is higher compared to western countries. There is a multitude of biomarkers associated with different clinical outcomes of TNBC with contradictory reports. Identification of a set of specific biomarkers from the very many number of proteins reported in the literature to predict prognosis of TNBC is an urgent clinical need. METHODOLOGY: A systematic review of key molecular biomarkers in cohort studies that have been investigated for their role in breast cancer prognosis was conducted...
April 13, 2024: Journal of Molecular Histology
https://read.qxmd.com/read/38610995/can-asiatic-acid-from-centella-asiatica-be-a-potential-remedy-in-cancer-therapy-a-review
#7
REVIEW
Michał Wiciński, Anna Fajkiel-Madajczyk, Zuzanna Kurant, Sandra Gajewska, Dominik Kurant, Marcin Kurant, Masaoud Sousak
Centella asiatica has been recognized for centuries in Eastern medicine for its pharmacological properties. Due to the increasing prevalence of oncological diseases worldwide, natural substances that could qualify as anticancer therapeutics are becoming increasingly important subjects of research. This review aims to find an innovative use for asiatic acid (AA) in the treatment or support of cancer therapy. It has been demonstrated that AA takes part in inhibiting phosphorylation, inducing cell death, and reducing tumor growth and metastasis by influencing important signaling pathways, such as PI3K, Akt, mTOR, p70S6K, and STAT3, in cancer cells...
March 28, 2024: Cancers
https://read.qxmd.com/read/38575404/predictors-of-biochemical-response-to-somatostatin-receptor-ligands-in-acromegaly
#8
REVIEW
Mónica Marazuela, Rebeca Martínez-Hernandez, Montserrat Marques-Pamies, Betina Biagetti, Marta Araujo-Castro, Manel Puig-Domingo
Although predictors of response to first-generation somatostatin receptor ligands (fg-SRLs), and to a lesser extent to pasireotide, have been studied in acromegaly for many years, their use is still not recommended in clinical guidelines. Is there insufficient evidence to use them? Numerous biomarkers including various clinical, functional, radiological and molecular markers have been identified. The first ones are applicable pre-surgery, while the molecular predictors are utilized for patients not cured after surgery...
March 19, 2024: Best Practice & Research. Clinical Endocrinology & Metabolism
https://read.qxmd.com/read/38558961/dysregulated-bidirectional-epithelial-mesenchymal-crosstalk-a-core-determinant-of-lung-fibrosis-progression
#9
JOURNAL ARTICLE
Liudi Yao, Zijian Xu, Donna E Davies, Mark G Jones, Yihua Wang
Progressive lung fibrosis is characterised by dysregulated extracellular matrix (ECM) homeostasis. Understanding of disease pathogenesis remains limited and has prevented the development of effective treatments. While an abnormal wound healing response is strongly implicated in lung fibrosis initiation, factors that determine why fibrosis progresses rather than regular tissue repair occurs are not fully explained. Within human lung fibrosis there is evidence of altered epithelial and mesenchymal lung populations as well as cells undergoing epithelial-mesenchymal transition (EMT), a dynamic and reversible biological process by which epithelial cells lose their cell polarity and down-regulate cadherin-mediated cell-cell adhesion to gain migratory properties...
March 2024: Chin Med J Pulm Crit Care Med
https://read.qxmd.com/read/38540190/potential-immunohistochemical-biomarkers-for-grading-oral-dysplasia-a-literature-review
#10
REVIEW
Jakub Zdrojewski, Monika Nowak, Kacper Nijakowski, Jakub Jankowski, Andrea Scribante, Simone Gallo, Maurizio Pascadopoli, Anna Surdacka
Oral cancer is a prevalent global health issue, with significant morbidity and mortality rates. Despite available preventive measures, it remains one of the most common cancers, emphasising the need for improved diagnostic and prognostic tools. This review focuses on oral potentially malignant disorders (OPMDs), precursors to oral cancer, specifically emphasising oral epithelial dysplasia (OED). The World Health Organisation (WHO) provides a three-tier grading system for OED, and recent updates have expanded the criteria to enhance diagnostic precision...
March 5, 2024: Biomedicines
https://read.qxmd.com/read/38532685/therapeutic-significance-of-long-noncoding-rnas-in-estrogen-receptor-positive-breast-cancer
#11
REVIEW
Abdullah Ali Alzahrani, Raed Obaid Saleh, Amaliya Latypova, Dmitry Olegovich Bokov, Anaheed Hussein Kareem, Hayder Abdullah Talib, Noora M Hameed, Atreyi Pramanik, Ahmed Alawadi, Ali Alsalamy
About 70% of cases of breast cancer are compromised by Estrogen-positive breast cancer. Through its regulation of several processes, including cell proliferation, cell cycle progression, and apoptosis, Estrogen signaling plays a pivotal role in the genesis and progression of this particular kind of breast cancer. One of the best treatment strategies for treating Estrogen-positive breast cancer is blocking Estrogen signaling. However, patients' treatment failure is mainly caused by the emergence of resistance and metastases, necessitating the development of novel therapeutic targets...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38515837/baicalin-administration-could-rescue-high-glucose-induced-craniofacial-skeleton-malformation-by-regulating-neural-crest-development
#12
JOURNAL ARTICLE
Jia-Qi Lu, Zhi-Yan Luo, Chengyang Sun, Si-Miao Wang, Dixiang Sun, Ruo-Jing Huang, Xuesong Yang, Yong Ding, Guang Wang
Hyperglycemia in pregnancy can increase the risk of congenital disorders, but little is known about craniofacial skeleton malformation and its corresponding medication. Our study first used meta-analysis to review the previous findings. Second, baicalin, an antioxidant, was chosen to counteract high glucose-induced craniofacial skeleton malformation. Its effectiveness was then tested by exposing chicken embryos to a combination of high glucose (HG, 50 mM) and 6 μM baicalin. Third, whole-mount immunofluorescence staining and in situ hybridization revealed that baicalin administration could reverse HG-inhibited neural crest cells (NCC) delamination and migration through upregulating the expression of Pax7 and Foxd3, and mitigate the disordered epithelial-mesenchymal transition (EMT) process by regulating corresponding adhesion molecules and transcription factors (i...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38498294/development-of-an-inflamed-high-throughput-stem-cell-based-gut-epithelium-model-to-assess-the-impact-of-annexin-a1
#13
JOURNAL ARTICLE
Milena Fronza Broering, Stefania Tocci, Noah T Sout, Chris Reutelingsperger, Sandra H P Farsky, Soumita Das, Ibrahim M Sayed
OBJECTIVE AND DESIGN: Annexin A1 (ANXA1) plays a role in maintaining intestinal hemostasis, especially following mucosal inflammation. The published data about ANXA1 was derived from experimental animal models where there is an overlapping between epithelial and immune cells. There is no in vitro gut epithelial model that can assess the direct effect of ANXA1 on the gut epithelium. METHODS: We developed high-throughput stem-cell-based murine epithelial cells and bacterial lipopolysaccharides (LPS) were used to induce inflammation...
March 18, 2024: Stem cell reviews and reports
https://read.qxmd.com/read/38473317/melatonin-and-its-role-in-the-epithelial-to-mesenchymal-transition-emt-in-cancer
#14
REVIEW
Carlos Martínez-Campa, Virginia Álvarez-García, Carolina Alonso-González, Alicia González, Samuel Cos
The epithelial-to-mesenchymal transition (EMT) is a cell-biological program that occurs during the progression of several physiological processes and that can also take place during pathological situations such as carcinogenesis. The EMT program consists of the sequential activation of a number of intracellular signaling pathways aimed at driving epithelial cells toward the acquisition of a series of intermediate phenotypic states arrayed along the epithelial-mesenchymal axis. These phenotypic features include changes in the motility, conformation, polarity and functionality of cancer cells, ultimately leading cells to stemness, increased invasiveness, chemo- and radioresistance and the formation of cancer metastasis...
February 27, 2024: Cancers
https://read.qxmd.com/read/38421701/molecular-mechanism-of-sox18-in-lipopolysaccharide-induced-injury-of-human-umbilical-vein-endothelial-cells
#15
JOURNAL ARTICLE
Jian Luo, Honglong Fang, Danqiong Wang, Jianhua Hu, Weiwen Zhang, Ronglin Jiang
Endothelial dysfunction is associated with the progression of sepsis. This study sought to probe the molecular route of sex-determining region on the Y chromosome-box transcription factor 18 (SOX18) in sepsis-associated endothelial injury. Human umbilical vein endothelial cells (HUVECs) were treated with lipopolysaccharide (LPS) to establish the sepsis cell model. Cell viability, lactate dehydrogenase (LDH) release, oxidative stress (reactive oxygen species/malondialdehyde/superoxide dismutase), and inflammation (interleukin-1β/tumor necrosis factor-α/interleukin-6) were evaluated by cell counting kit-8 assay and relevant assay kits...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38394940/cdh1-gene-mutation-a-challenging-surgical-topic-case-report-and-literature-review
#16
Hani Maalouf, Toufic Saber, Souad Ghattas, Zarouhie Meguerian-Bedoyan, Ziad El Rassi
INTRODUCTION: Gastric cancer is one of the top 5 cancers worldwide. Most gastric cancers are classified as sporadic with the exception of around 3 % that are associated with specific syndromes or genes. Hereditary diffuse gastric cancer is a very rare type of gastric cancer, associated with loss of function of a tumor suppressor gene CDH1 which has a high penetrance that can reach 90 % over a lifetime. CASE PRESENTATION: Here we present the case of a 31 years old male patient carrying the CDH1 gene who presented for prophylactic total gastrectomy and D1 lymphadenectomy followed by a roux en y esophago-jejunostomy for digestive tract reconstruction...
February 21, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38373660/e-cadherin-re-expression-its-potential-in-combating-trail-resistance-and-reversing-epithelial-to-mesenchymal-transition
#17
REVIEW
Ser Hui San, Siew Ching Ngai
The major limitation of conventional chemotherapy drugs is their lack of specificity for cancer cells. As a selective apoptosis-inducing agent, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has emerged as an attractive alternative. However, most of the cancer cells are found to be either intrinsically resistant to the TRAIL protein or may develop resistance after multiple treatments, and TRAIL resistance can induce epithelial-to-mesenchymal transition (EMT) at a later stage, promoting cancer invasion and migration...
February 17, 2024: Gene
https://read.qxmd.com/read/38361784/hmga2-promotes-cancer-metastasis-by-regulating-epithelial-mesenchymal-transition
#18
REVIEW
Qing Ma, Sisi Ye, Hong Liu, Yu Zhao, Yan Mao, Wei Zhang
Epithelial-mesenchymal transition (EMT) is a complex physiological process that transforms polarized epithelial cells into moving mesenchymal cells. Dysfunction of EMT promotes the invasion and metastasis of cancer. The architectural transcription factor high mobility group AT-hook 2 (HMGA2) is highly overexpressed in various types of cancer (e.g., colorectal cancer, liver cancer, breast cancer, uterine leiomyomas) and significantly correlated with poor survival rates. Evidence indicated that HMGA2 overexpression markedly decreased the expression of epithelial marker E-cadherin (CDH1) and increased that of vimentin (VIM), Snail, N-cadherin (CDH2), and zinc finger E-box binding homeobox 1 (ZEB1) by targeting the transforming growth factor beta/SMAD (TGFβ/SMAD), mitogen-activated protein kinase (MAPK), and WNT/beta-catenin (WNT/β-catenin) signaling pathways...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38323651/endothelial-neuropilin-1-a-multifaced-signal-transducer-with-an-emerging-role-in-inflammation-and-atherosclerosis-beyond-angiogenesis
#19
JOURNAL ARTICLE
Anissa Chikh, Claudio Raimondi
Neuropilin-1 (NRP1) is a transmembrane glycoprotein expressed by several cell types including, neurons, endothelial cells (ECs), smooth muscle cells, cardiomyocytes and immune cells comprising macrophages, dendritic cells and T cell subsets. Since NRP1 discovery in 1987 as an adhesion molecule in the frog nervous system, more than 2300 publications on PubMed investigated the function of NRP1 in physiological and pathological contexts. NRP1 has been characterised as a coreceptor for class 3 semaphorins and several members of the vascular endothelial growth factor (VEGF) family...
February 7, 2024: Biochemical Society Transactions
https://read.qxmd.com/read/38302794/cellular-junction-dynamics-and-alzheimer-s-disease-a-comprehensive-review
#20
REVIEW
Keyvan Asghari, Zahra Niknam, Shadi Mohammadpour-Asl, Leila Chodari
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by progressive neuronal damage and cognitive decline. Recent studies have shed light on the involvement of not only the blood-brain barrier (BBB) dysfunction but also significant alterations in cellular junctions in AD pathogenesis. In this review article, we explore the role of the BBB and cellular junctions in AD pathology, with a specific focus on the hippocampus. The BBB acts as a crucial protective barrier between the bloodstream and the brain, maintaining brain homeostasis and regulating molecular transport...
February 1, 2024: Molecular Biology Reports
keyword
keyword
66067
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.